Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 113 of 113 entries
View as:

A Study to Evaluate How Well Single and Multiple Doses of GLPG3667 Are Tolerated in Healthy, Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04976270 Org: User:
Start: 07/20/21 End: 01/14/22 Due: 01/14/23

A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03568071 Org: User:
Start: 04/26/18 End: 03/03/20 Due: 03/03/21

A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06561425 Org: User:
Start: 03/09/22 End: 07/01/29 Due: 07/01/30

Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04736927 Org: User:
Start: 01/15/21 End: 02/25/21 Due: 02/25/22

A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05856448 Org: User:
Start: 06/28/23 End: 03/31/26 Due: 03/31/27

First-in-Human Single Ascending and Multiple Dose of GLPG0634

Phase: N/A Priority: Normal
NCT ID: NCT01179581 Org: User:
Start: 08/31/10 End: 03/31/11 Due: 03/31/12

A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an Injection

Phase: N/A Priority: Normal
NCT ID: NCT04136327 Org: User:
Start: 09/13/19 End: 10/21/19 Due: 10/21/20

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

Phase: N/A Priority: Normal
NCT ID: NCT05695950 Org: User:
Start: 02/27/23 End: 04/30/26 Due: 04/30/27

A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970

Phase: N/A Priority: Normal
NCT ID: NCT04106297 Org: User:
Start: 09/10/19 End: 03/05/21 Due: 03/05/22

A Study Investigating the Safety, Absorption and Elimination of GLPG3312, a New Drug in the Treatment of Inflammatory Diseases

Phase: N/A Priority: Normal
NCT ID: NCT03800472 Org: User:
Start: 01/15/19 End: 03/10/20 Due: 03/10/21

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970

Phase: N/A Priority: Normal
NCT ID: NCT04907149 Org: User:
Start: 06/07/21 End: 07/12/21 Due: 07/12/22

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

Phase: N/A Priority: Normal
NCT ID: NCT02065700 Org: User:
Start: 02/25/14 End: 01/19/23 Due: 01/19/24

Study of GLPG1837 in Subjects With Cystic Fibrosis (S1251N Mutation)

Phase: N/A Priority: Normal
NCT ID: NCT02690519 Org: User:
Start: 01/31/16 End: 09/30/16 Due: 09/30/17